Disease free survival and overall survival. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy5

Lymph Nodes Cell Line, Tumor Cells, Cultured Bone Marrow Neoplastic Cells, Circulating

Organisms3

Mice, Inbred C57BL Mice, Knockout Mice, Inbred BALB C

Diseases72

Neoplasm Recurrence, Local Breast Neoplasms Lymphatic Metastasis Carcinoma, Squamous Cell Colorectal Neoplasms Adenocarcinoma Liver Neoplasms Recurrence Neoplasm Invasiveness Carcinoma Neoplasm Metastasis Lung Neoplasms Carcinoma, Ductal, Breast Disease Progression Carcinoma, Non-Small-Cell Lung Ovarian Neoplasms Bone Neoplasms Brain Neoplasms Head and Neck Neoplasms Carcinoma, Hepatocellular Sarcoma Lymphoma, Non-Hodgkin Hodgkin Disease Stomach Neoplasms Pancreatic Neoplasms Melanoma Multiple Myeloma Rectal Neoplasms Kidney Neoplasms Neoplasm, Residual Osteosarcoma Glioblastoma Carcinoma, Renal Cell Neoplasms, Germ Cell and Embryonal Nasopharyngeal Neoplasms Skin Neoplasms Prostatic Neoplasms Neoplasms, Glandular and Epithelial Soft Tissue Neoplasms Leukemia, Myeloid, Acute Precursor Cell Lymphoblastic Leukemia-Lymphoma Urinary Bladder Neoplasms Lymphoma, Large B-Cell, Diffuse Esophageal Neoplasms Adenocarcinoma, Mucinous Endometrial Neoplasms Uterine Cervical Neoplasms Mediastinal Neoplasms Colonic Neoplasms Gastrointestinal Neoplasms Testicular Neoplasms Postoperative Complications Neoplasms Lymphoma, Follicular Glioma Central Nervous System Neoplasms Peritoneal Neoplasms Leukemia, Lymphocytic, Chronic, B-Cell Graft vs Host Disease Myelodysplastic Syndromes Neutropenia Disease Models, Animal Oropharyngeal Neoplasms Cholangiocarcinoma Lymphoma, B-Cell Neoplastic Cells, Circulating Bile Duct Neoplasms Carcinoma, Small Cell Carcinoma, Transitional Cell Acute Disease Leukemia, Myeloid Neoplasms, Second Primary

Chemicals and Drugs67

Tumor Markers, Biological Fluorouracil Cyclophosphamide Antineoplastic Agents Cisplatin Receptor, erbB-2 Receptors, Estrogen Vincristine Doxorubicin Etoposide Prednisone Deoxycytidine Methotrexate Carboplatin Paclitaxel Organoplatinum Compounds Receptors, Progesterone Antibodies, Monoclonal, Humanized Leucovorin Antimetabolites, Antineoplastic Antibodies, Monoclonal Taxoids Antineoplastic Agents, Hormonal Neoplasm Proteins Antineoplastic Agents, Alkylating Tamoxifen Cytarabine Bleomycin Antibodies, Monoclonal, Murine-Derived Dacarbazine Ki-67 Antigen Vinblastine Ifosfamide Free Radicals Receptor, Epidermal Growth Factor Tumor Suppressor Protein p53 Protein Kinase Inhibitors Antineoplastic Agents, Phytogenic Camptothecin RNA, Messenger Angiogenesis Inhibitors Melphalan Procarbazine Epirubicin Thalidomide Antigens, Neoplasm Quinazolines Niacinamide Anthracyclines Platinum Compounds Proto-Oncogene Proteins Phenylurea Compounds Mitoxantrone Benzenesulfonates Mechlorethamine Carmustine Lomustine Vidarabine Daunorubicin Pyrimidines Tegafur Survival of Motor Neuron 1 Protein Antibiotics, Antineoplastic Immunosuppressive Agents Interferon-alpha Benzamides Dexamethasone

Analytical, Diagnostic and Therapeutic Techniques and Equipment87

Disease-Free Survival Survival Rate Prognosis Survival Analysis Neoplasm Staging Treatment Outcome Retrospective Studies Kaplan-Meier Estimate Combined Modality Therapy Antineoplastic Combined Chemotherapy Protocols Follow-Up Studies Chemotherapy, Adjuvant Proportional Hazards Models Radiotherapy, Adjuvant Immunohistochemistry Radiotherapy Dosage Multivariate Analysis Prospective Studies Predictive Value of Tests Immunoenzyme Techniques Risk Factors Remission Induction Drug Administration Schedule Neoadjuvant Therapy Neoplasm Grading Salvage Therapy Chemoradiotherapy Cohort Studies Radiotherapy Transplantation, Autologous Hematopoietic Stem Cell Transplantation Transplantation, Homologous Lymph Node Excision Actuarial Analysis Risk Assessment Brachytherapy Dose Fractionation Randomized Controlled Trials as Topic Tissue Array Analysis Reverse Transcriptase Polymerase Chain Reaction Hepatectomy Tumor Burden Clinical Trials as Topic Registries Clinical Trials, Phase III as Topic Gene Expression Profiling Radiotherapy, Intensity-Modulated Bone Marrow Transplantation Life Tables Radiotherapy, Conformal Chi-Square Distribution Mastectomy Treatment Failure Peripheral Blood Stem Cell Transplantation Infusions, Intravenous Induction Chemotherapy Tomography, X-Ray Computed SEER Program Transplantation Conditioning Analysis of Variance Risk Clinical Trials, Phase II as Topic Palliative Care Case-Control Studies Probability Chemoradiotherapy, Adjuvant Stem Cell Transplantation Liver Transplantation Patient Selection Blotting, Western Incidence Chemoembolization, Therapeutic Cranial Irradiation Esophagectomy Disease Models, Animal Cause of Death In Situ Hybridization, Fluorescence Gastrectomy Nomograms Radiosurgery Cystectomy Reoperation Regression Analysis Statistics, Nonparametric Multicenter Studies as Topic Oligonucleotide Array Sequence Analysis Preoperative Care

Phenomena and Processes16

Cell Survival Time Factors Graft Survival Gene Expression Regulation, Neoplastic Apoptosis Drug Resistance, Neoplasm Mutation Cell Proliferation Dose-Response Relationship, Drug Signal Transduction Chi-Square Distribution Risk Probability Graft Rejection Nomograms Gene Expression

Disciplines and Occupations1

Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena2

Survival Quality of Life

Humanities1

Quality of Life

Information Science8

Survival Rate Registries Radiotherapy, Intensity-Modulated Life Tables Radiotherapy, Conformal SEER Program Incidence Cause of Death

Named Groups2

Tissue Donors Infant, Newborn

Health Care38

Disease-Free Survival Survival Rate Survival Analysis Treatment Outcome Retrospective Studies Kaplan-Meier Estimate Follow-Up Studies Proportional Hazards Models Multivariate Analysis Prospective Studies Predictive Value of Tests Risk Factors Cohort Studies Age Factors Actuarial Analysis Risk Assessment Randomized Controlled Trials as Topic Clinical Trials as Topic Registries Clinical Trials, Phase III as Topic Life Tables Chi-Square Distribution Treatment Failure SEER Program Analysis of Variance Risk Clinical Trials, Phase II as Topic Palliative Care Case-Control Studies Probability Patient Selection Incidence Cause of Death Nomograms Regression Analysis Statistics, Nonparametric Multicenter Studies as Topic Preoperative Care

Geographicals2

United States Egypt

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Health Care

Disease-Free Survival Survival Rate Prognosis Survival Analysis Neoplasm Staging Treatment Outcome Retrospective Studies Kaplan-Meier Estimate Combined Modality Therapy Neoplasm Recurrence, Local Antineoplastic Combined Chemotherapy Protocols Breast Neoplasms Follow-Up Studies Cell Survival Chemotherapy, Adjuvant Tumor Markers, Biological Proportional Hazards Models Lymphatic Metastasis Radiotherapy, Adjuvant Immunohistochemistry Fluorouracil Time Factors Survival Radiotherapy Dosage Multivariate Analysis Cyclophosphamide Carcinoma, Squamous Cell Colorectal Neoplasms Adenocarcinoma Liver Neoplasms Recurrence Neoplasm Invasiveness Carcinoma Prospective Studies Antineoplastic Agents Neoplasm Metastasis Cisplatin Lung Neoplasms Graft Survival Carcinoma, Ductal, Breast Predictive Value of Tests Receptor, erbB-2 Receptors, Estrogen Immunoenzyme Techniques Vincristine Risk Factors Gene Expression Regulation, Neoplastic Doxorubicin Disease Progression Remission Induction Drug Administration Schedule Neoadjuvant Therapy Carcinoma, Non-Small-Cell Lung Neoplasm Grading Salvage Therapy Etoposide Prednisone Chemoradiotherapy Ovarian Neoplasms Cohort Studies Bone Neoplasms Brain Neoplasms Deoxycytidine Methotrexate Carboplatin Radiotherapy Head and Neck Neoplasms Carcinoma, Hepatocellular Transplantation, Autologous Sarcoma Age Factors Lymphoma, Non-Hodgkin Hematopoietic Stem Cell Transplantation Paclitaxel Hodgkin Disease Organoplatinum Compounds Stomach Neoplasms Pancreatic Neoplasms Receptors, Progesterone Transplantation, Homologous Antibodies, Monoclonal, Humanized Lymph Node Excision Actuarial Analysis Leucovorin Risk Assessment Antimetabolites, Antineoplastic Antibodies, Monoclonal Lymph Nodes Melanoma Brachytherapy Dose Fractionation Multiple Myeloma Taxoids Cell Line, Tumor Antineoplastic Agents, Hormonal Rectal Neoplasms Neoplasm Proteins Kidney Neoplasms Neoplasm, Residual Apoptosis

No FAQ available that match "disease free survival and overall survival"